Overview

Price chart · mood · technical indicators

BNGO

Bionano Genomics Incstock Healthcare

Medical Instruments & Supplies

$1.2466.49%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$1.06$5.50

Current: $1.24

Market Comparison

vs Healthcare Sector & Medical Instruments & Supplies Industry

BNGO

-66.49%

1Y Performance

Healthcare

Sector 1Y

Medical Instruments & Supplies

Industry 1Y

Fundamentals

Updated daily after market close

P/E ratio—

EPS (TTM)$-4.850.0% YoY

Profit margin-92.6%HEALTHCARE

Market cap$13.1MMicro cap

Wall Street coverage

$5.00median target· current $59.79 (-91.6%)2 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: —
PEG ratio: —
P/B: 0.29
P/S (TTM): 0.46
EV/EBITDA: -0.17

Profitability & growth

ROE (TTM): -66.1%
Operating margin: -107.4%
Revenue growth YoY: -2.6%
Dividend yield: —
Beta: 1.60

Last earnings

Mar 24, 2026 · Estimate $-4.14 · Reported $-0.03

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Bionano Genomics Inc

Company profile

Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.

Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$13.1M

Shares outstanding$11.1M

52W high$5.50

52W low$1.06

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

BNGO

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Bionano schedules May 13 webcast to discuss first-quarter results

Bionano Genomics (Nasdaq:BNGO) - Stock Analysis

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus

BNGO Should I Buy

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

Bionano Genomics stock price target lowered to $6 by H.C. Wainwright

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO)

BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison

[ARS] Bionano Genomics, Inc. SEC Filing

Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

In 211 myeloma samples, OGM found abnormalities older tests missed

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Bionano Genomics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BNGO)

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript

About Bionano Genomics Inc

Classification

Company profile

BNGO

Market Comparison

BNGO Market Analysis

Overview

BNGO

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026

Bionano schedules May 13 webcast to discuss first-quarter results

Bionano Genomics (Nasdaq:BNGO) - Stock Analysis

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus

Earnings Snapshot: Bionano Genomics sees Q4, FY25 revenue below analysts' consensus

BNGO Should I Buy

H.C. Wainwright Maintains Bionano Genomics(BNGO.US) With Buy Rating, Cuts Target Price to $6

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

Bionano Genomics stock price target lowered to $6 by H.C. Wainwright

Keys to Succeed in the Booming $300 Million Optical Genome Mapping Market 2026-2030: Bionano Genomics, 10x Genomics, and Oxford Nanopore Technologies Lead

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ) and BioNano Genomics (BNGO)

BNGO Financials: Revenue Breakdown, Margins & Competitor Comparison

[ARS] Bionano Genomics, Inc. SEC Filing

Bionano Genomics (NASDAQ: BNGO) outlines 2026 virtual meeting and proxy votes

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

In 211 myeloma samples, OGM found abnormalities older tests missed

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026

Bionano Genomics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BNGO)

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript

About Bionano Genomics Inc

Classification

Company profile

BNGO

Market Comparison